Recombinant diabody-based immunocapture enzyme-linked immunosorbent assay for quantification of rabies virus glycoprotein

Clinical and Vaccine Immunology

Volumn 17, Issue 8, 2010, Pages 1261-1268

  Nimmagadda, Sridevi V ^a   Aavula, Shukra M ^a   Biradhar, Neelakantam ^a   Rao, Varaprasada Sankarasetty ^a   Shanmugham, Rajalakshmi ^a   Chandran, Dev ^a   Thirumeni, Nagarajan ^a   Singanallur, Nagendrakumar Balasubramanian ^a   Villuppanoor, Srinivasan Alwar ^a  

^a Indian Immunologicals Limited   (India)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY; NITRILOTRIACETIC ACID; RABIES VACCINE; VIRUS GLYCOPROTEIN; GLYCOPROTEIN; RECOMBINANT PROTEIN; VIRUS ANTIBODY; VIRUS PROTEIN;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RABIES VIRUS; ANIMAL; CHEMISTRY; DIAGNOSTIC USE; EVALUATION STUDY; IMMUNOLOGY; ISOLATION AND PURIFICATION; PHARMACEUTICS; PROCEDURES; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; STANDARDS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HUMANS; MICE; QUALITY CONTROL; RABIES VACCINES; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; TECHNOLOGY, PHARMACEUTICAL; VIRAL PROTEINS;

EID: 77955293172     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00204-10     Document Type: Article

References (25)

1. Alfthan, K., K. Takkinen, D. Sizmann, H. Söderlund, and T. T. Teeri. 1995. Properties of a single-chain antibody containing different linker peptides. Protein Eng. 8(7):725-731.
2. Blancou, J., M. F. Aubert, E. Cain, M. Selve, O. Thraenhart, and L. Bruckner. 1989. Effect of strain differences on the potency testing of rabies vaccines in mice. J. Biol. Stand. 17:259-266.
3. Bronnert, J., H. Wilde, V. Tepsumethanon, B. Lumlertdacha, and T. Hemachudha. 2007. Organ transplantations and rabies transmission. J. Travel Med. 14:177-180.
4. Cheung, S. C., B. Dietzschold, H. Koproswski, A. L. Notkins, and R. F. Rando. 1992. A recombinant human Fab expressed in Escherichia coli neutralizes rabies virus. J. Virol. 66:6714-6720.
5. Constantine, D. L. 1962. Rabies transmission by the non-bite route. Public Health Rep. 77:287-289.
6. Favoretto, S. R., C. C. de Mattos, N. B. de Morais, M. L. Carrieri, B. N. Rolim, L. M. Silva, C. E. Rupprecht, E. L. Durigon, and C. A. de Mattos. 2006. Rabies virus maintained by dogs in humans and terrestrial wildlife, Ceara State, Brazil. Emerg. Infect. Dis. 12:1978-1981.
7. Ferguson, M., and A. Heath. 1992. Report of a collaborative study to assess the determination of glycoprotein antigen content of rabies vaccines for human use. Biologicals 20:143-154.
8. Fournier-Caruana, J., B. Poirier, G. Haond, C. Jallet, F. Fuchs, N. Tordo, and P. Perrin. 2003. Inactivated rabies vaccine control and release: use of an ELISA method. Biologicals 31(1):9-16.
9. Gamoh, K., M. Senda, O. Itoh, M. Muramatsu, N. Hirayama, R. Koike, Y. S. Endoh, and N. Minamoto. 1996. Use of ELISA for in vitro potency test of rabies vaccines for animal use. Biologicals 24(2):95-101.
10. Holliger, P., T. Prospero, and G. Winter. 1993. Diabodies: small bivalent and bispecific antibody fragments. Proc. Natl. Acad. Sci. U. S. A. 90(14):6444-6448.
11. Knobel, D. L., S. Cleaveland, P. G. Coleman, E. M. Fèvre, M. I. Meltzer, M. E. Miranda, A. Shaw, J. Zinsstag, and F. X. Meslin. 2005. Re-evaluating the burden of rabies in Africa and Asia. Bull. World Health Organ. 83:360-368.
12. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
13. Lafon, M., P. Perrin, P. Versmisse, and P. Sureau. 1985. Use of a monoclonal antibody for quantification of rabies vaccine glycoprotein by enzyme immunoassay. J. Biol. Stand. 13:295-301.
14. Lindbladh, C., K. Mosbach, and L. Bülow. 1993. Use of genetically prepared enzyme conjugates in enzyme immunoassay. Trends Biochem. Sci. 18(8):279-283.
15. Marks, J. D., H. R. Hoogenboom, T. P. Bonnert, J. McCafferty, A. D. Griffiths, and G. Winter. 1991. By-passing immunization: human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222:581-597.
16. McCafferty, J., A. D. Griffiths, G. Winter, and D. J. Chiswell. 1990. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348:552-554.
17. Mousli, M., I. Turki, H. Kharmachi, M. Saadi, and K. Dellagi. 2007. Recombinant single-chain Fv antibody fragment-alkaline phosphatase conjugate: a novel in vitro tool to estimate rabies viral glycoprotein antigen in vaccine manufacture. J. Virol. Methods 146(1-2):246-256.
18. Nagarajan, T., G. S. Reddy, B. Mohana Subramanian, S. Rajalakshmi, D. Thiagarajan, N. Tordo, C. Jallet, and V. A. Srinivasan. 2006. A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture. Biologicals 34:21-27.
19. Orlandi, R., D. H. Güssow, P. T. Jones, and G. Winter. 1989. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc. Natl. Acad. Sci. U. S. A. 86(10):3833-3837.
20. Perrin, P., S. Morgeaux, and P. Sureau. 1990. In vitro rabies vaccine potency appraisal by ELISA: advantages of the immunocapture method with a neutralizing anti-glycoprotein monoclonal antibody. Biologicals 18:321-330.
21. Sudarshan, M. K., S. N. Madhusudana, B. J. Mahendra, N. S. Rao, D. H. Ashwathnarayana, S. Abdul Rahman, F. X. Meslin, D. Lobo, K. Ravikumar, and Gangaboraiah. 2007. Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey. Int. J. Infect. Dis. 11:29-35.
22. Snedecor, G. W., and W. G. Cochran. 1989. Statistical methods applied to experiments in agriculture and biology, 8th ed. Iowa State University Press, Ames, IA.
23. Wilber, L. A., and M. F. A. Aubert. 1996. The NIH test for potency, p. 360-368. In F. X. Meslin, M. M. Kaplan, and H. Koprowski (ed.), Laboratory techniques in rabies, 4th ed. WHO, Geneva, Switzerland.
24. WHO. 1988. Potency and stability of various modern rabies vaccines for veterinary use. http://whqlibdoc.who.int/hq/1988/WHO-Rab.Res.-88.28.pdf. WHO, Geneva, Switzerland.
25. WHO. 2001. Rabies. Fact sheet no. 99. WHO, Geneva, Switzerland.